The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug
Abstract
Previous research has shown drug-free Ecstasy users to demonstrate selective cognitive impairment However, there seems to be a degree of individual variation in the occurrence of such deficits. The present study aimed to assess whether these cognitive deficits are related to an awareness of problematic Ecstasy use, or to past drug dosage. Twenty regular Ecstasy users who reported experiencing Ecstasy-related problems were compared with 20 Ecstasy users who had not reported any previous problems. The two groups displayed similar past histories in relation to a range of illicit drugs, and were divided into low, medium and high users. The controls comprised 20 illicit recreational drug users who had never taken Ecstasy. Executive task measures comprised the Tower of London (TOL), the Wisconsin Card Sorting Task (WCST) and spatial working memory. Immediate and delayed word recall, matched verbal recognition and recall and simple reaction time were also included. Both Ecstasy groups performed significantly worse than controls on two executive measures: TOL planning time and spatial working memory score. There were no differences in cognitive impairment between the Ecstasy users who complained of problems and those who did not. In both groups, decrement on executive tasks was demonstrated as a function of previous drug dose. The study confirms that heavy Ecstasy polydrug use may culminate in selective executive deficits. It also demonstrates that two differently self-perceived Ecstasy groups showed similar cognitive impairment, despite only one group complaining of problems. Because all Ecstasy participants also consumed a range of other illicit drugs, the results are reflective of Ecstasy polydrug use in individuals who use Ecstasy as a drug of preference.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neural systems engaged by planning: A PET study of the Tower of London task
Baker, S. C., Rogers, R. D., Owen, A. M., Frith, C. D., Dolan, R. J., Frackowiak, R. S. J., & Robbins, T. W. (1996) · Neuropsychologia · doi:10.1016/0028-3932(95)00133-6 · Cited by 635
Cohen, J. D., Braver, T. S., & O´Reilly, R. (1996) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1996.0138 · Cited by 487
Cognitive Function Following Acute Sleep Restriction in Children Ages 10–14
(1998) · Sleep · doi:10.1093/sleep/21.8.861 · Cited by 430
Roberts, A., De Salvia, M., Wilkinson, L., Collins, P., Muir, J., Everitt, B., & Robbins, T. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-05-02531.1994 · Cited by 415
ELLIOTT, R., BAKER, S. C., ROGERS, R. D., O'LEARY, D. A., PAYKEL, E. S., FRITH, C. D., DOLAN, R. J., & SAHAKIAN, B. J. (1997) · Psychological Medicine · doi:10.1017/s0033291797005187 · Cited by 307
Cited by
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
Green, A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., & Colado, M. I. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.3 · Cited by 1,272
Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research
Parrott, A. C. (2001) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.351 · Cited by 344
Self-citationRecreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity
Parrott, A. C. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00711-0 · Cited by 324
Self-citationVerdejo-García, A., & Pérez-García, M. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0632-8 · Cited by 303
The relationship between non‐acute adolescent cannabis use and cognition
HARVEY, M. A., SELLMAN, J. D., PORTER, R. J., & FRAMPTON, C. M. (2007) · Drug and Alcohol Review · doi:10.1080/09595230701247772 · Cited by 222
Metadata
- Authors
- Fox, H. C., Parrott, A. C., & Turner, J. J. D.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2001-07
- Volume
- 15
- Issue
- 4
- Pages
- 273-281
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2010260292
- Cited by
- 170
- References
- 5
- FWCI
- 15.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug. https://app.cochat.ai/papers/10.1177/026988110101500406
- The paper
- Fox, H. C., Parrott, A. C., & Turner, J. J. D. (2001). Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug. Journal of Psychopharmacology. https://doi.org/10.1177/026988110101500406
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.